Trigilio Jeffrey
SEC CIK 1838671 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | CFO | 133.9K | — | $689.7K | 20 | 2021-09-08 | 2024-02-22 |
Most active insiders at CGEM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 10% | $11.93M | — |
| 2 | Michaelson Jennifer | CSO | — | $1.62M |
| 3 | Nichols Weston | 10% | $1.39M | — |
| 4 | AHMED NADIM | Pres, CEO, Dir | — | $518.0K |
| 5 | Jones Jeffrey Alan | Chief Medical Off | — | $178.9K |
| 6 | SUMER JACQUELYN L | CLO | — | $136.7K |
| 7 | Fenton Mary Kay | CFO | — | $59.9K |
Trigilio Jeffrey made no open-market trades at CGEM in the last 12 months.
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-23 | 2024-02-22 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | A - Grant | $0.00 | +50.0K | 133.9K | +60% | $0 |
| 2023-12-22 | 2023-12-21 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale | $8.50 | -1,920 | 83.9K | -2% | -$16.3K | |
| 2023-12-20 | 2023-12-18 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale | $8.22 | -398 | 85.8K | -0.5% | -$3,272 | |
| 2023-12-13 | 2023-12-12 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale | $7.81 | -1,926 | 86.2K | -2% | -$15.0K | |
| 2023-07-05 | 2023-06-30 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | A - Grant | $9.08 | +2,340 | 88.2K | +3% | +$21.2K | |
| 2023-06-21 | 2023-06-20 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale | $12.94 | -399 | 85.8K | -0.5% | -$5,163 | |
| 2023-06-14 | 2023-06-12 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale | $13.11 | -319 | 86.2K | -0.4% | -$4,182 | |
| 2023-05-19 | 2023-05-18 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale | $8.76 | -399 | 86.5K | -0.5% | -$3,495 | |
| 2023-05-16 | 2023-05-12 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale | $8.78 | -347 | 86.9K | -0.4% | -$3,047 | |
| 2023-04-20 | 2023-04-18 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale | $10.71 | -398 | 87.3K | -0.5% | -$4,263 | |
| 2023-04-14 | 2023-04-12 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale | $10.22 | -318 | 87.7K | -0.4% | -$3,250 | |
| 2023-03-27 | 2023-03-20 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale | $11.32 | -399 | 88.0K | -0.5% | -$4,517 | |
| D | 2023-02-21 | 2023-02-17 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | A - Grant | $0.00 | +47.0K | 88.4K | +114% | $0 |
| 2023-01-06 | 2022-12-30 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | A - Grant | $8.97 | +201 | 41.4K | +0.5% | +$1,803 | |
| 2022-07-05 | 2022-06-30 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | A - Grant | $10.90 | +1,451 | 41.2K | +4% | +$15.8K | |
| D | 2022-02-15 | 2022-02-11 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | A - Grant | $0.00 | +37.5K | 39.8K | +1,667% | $0 |
| D | 2021-10-18 | 2021-10-15 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale+OE | $25.00 | -8,000 | 2,250 | -78% | -$200.0K |
| D | 2021-10-18 | 2021-10-15 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | M - OptEx | $4.30 | +8,000 | 10.2K | +356% | +$34.4K |
| D | 2021-09-09 | 2021-09-08 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | M - OptEx | $4.30 | +15.0K | 17.2K | +667% | +$64.5K |
| DM | 2021-09-09 | 2021-09-08 | CGEM | Cullinan Therapeutics, Inc. | Trigilio Jeffrey | CFO | S - Sale+OE | $28.48 | -15.0K | 11.8K | -56% | -$427.2K |
Purchase Sale Sale after option exercise All abbreviations